Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International

Wikipedia Affiliate Button

Home > Press > New nanodevice defeats drug resistance: Tiny particles embedded in gel can turn off drug-resistance genes, then release cancer drugs

At left is the new nanodevice, consisting of a hydrogel embedded with gold nanoparticles coated with DNA targeting a gene called MRP-1. At right, the device fluoresces after encountering the target gene sequence.

Courtesy of the researchers
At left is the new nanodevice, consisting of a hydrogel embedded with gold nanoparticles coated with DNA targeting a gene called MRP-1. At right, the device fluoresces after encountering the target gene sequence.

Courtesy of the researchers

Abstract:
Chemotherapy often shrinks tumors at first, but as cancer cells become resistant to drug treatment, tumors can grow back. A new nanodevice developed by MIT researchers can help overcome that by first blocking the gene that confers drug resistance, then launching a new chemotherapy attack against the disarmed tumors.

New nanodevice defeats drug resistance: Tiny particles embedded in gel can turn off drug-resistance genes, then release cancer drugs

Cambridge, MA | Posted on March 2nd, 2015

The device, which consists of gold nanoparticles embedded in a hydrogel that can be injected or implanted at a tumor site, could also be used more broadly to disrupt any gene involved in cancer.

"You can target any genetic marker and deliver a drug, including those that don't necessarily involve drug-resistance pathways. It's a universal platform for dual therapy," says Natalie Artzi, a research scientist at MIT's Institute for Medical Engineering and Science (IMES), an assistant professor at Harvard Medical School, and senior author of a paper describing the device in the Proceedings of the National Academy of Sciences the week of March 2.

To demonstrate the effectiveness of the new approach, Artzi and colleagues tested it in mice implanted with a type of human breast tumor known as a triple negative tumor. Such tumors, which lack any of the three most common breast cancer markers -- estrogen receptor, progesterone receptor, and Her2 -- are usually very difficult to treat. Using the new device to block the gene for multidrug resistant protein 1 (MRP1) and then deliver the chemotherapy drug 5-fluorouracil, the researchers were able to shrink tumors by 90 percent in two weeks.

Overcoming resistance

MRP1 is one of many genes that can help tumor cells become resistant to chemotherapy. MRP1 codes for a protein that acts as a pump, eliminating cancer drugs from tumor cells and rendering them ineffective. This pump acts on several drugs other than 5-fluorouracil, including the commonly used cancer drug doxorubicin.

"Drug resistance is a huge hurdle in cancer therapy and the reason why chemotherapy, in many cases, is not very effective", says Joćo Conde, an IMES postdoc and lead author of the PNAS paper.

To overcome this, the researchers created gold nanoparticles coated with strands of DNA complementary to the sequence of MRP1 messenger RNA -- the snippet of genetic material that carries DNA's instructions to the rest of the cell.

These strands of DNA, which the researchers call "nanobeacons," fold back on themselves to form a closed hairpin structure. However, when the DNA encounters the correct mRNA sequence inside a cancer cell, it unfolds and binds to the mRNA, preventing it from generating more molecules of the MRP1 protein. As the DNA unfolds, it also releases molecules of 5-fluorouracil that were embedded in the strand. This drug then attacks the tumor cell's DNA, since MRP1 is no longer around to pump it out of the cell.

"When we silence the gene, the cell is no longer resistant to that drug, so we can deliver the drug that now regains its efficacy," Conde says.

When each of these events occurs -- sensing the MRP1 protein and releasing 5-fluorouracil -- the device emits fluorescence of different wavelengths, allowing the researchers to visualize what is happening inside the cells. Because of this, the particles could also be used for diagnosis -- specifically, determining if a certain cancer-related gene is activated in tumor cells.

Controlled drug release

The DNA-coated gold nanoparticles are embedded in an adhesive gel that stays in place and coats the tumor after being implanted. This local administration of the particles protects them from degradation that might occur if they were administered throughout the body, and also enables sustained drug release, Artzi says.

In their mouse studies, the researchers found that the particles could silence MRP1 for up to two weeks, with continuous drug release over that time, effectively shrinking tumors.

This approach could be adapted to deliver any kind of drug or gene therapy targeted to a specific gene involved in cancer, the researchers say. They are now working on using it to silence a gene that stimulates gastric tumors to metastasize to the lungs.

###

Graduate student Nuria Oliva is also an author of the paper. The research was funded by the National Cancer Institute and a Marie Curie International Outgoing Fellowship.

####

For more information, please click here

Contacts:
Sarah McDonnell

617-253-8923

Copyright © Massachusetts Institute of Technology

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

'Hot spots' increase efficiency of solar desalination: Rice University engineers boost output of solar desalination system by 50% June 19th, 2019

New record: 3D-printed optical-electronic integration June 18th, 2019

Can break junction techniques still offer quantitative information at single-molecule level June 18th, 2019

Small currents for big gains in spintronics: A new low-power magnetic switching component could aid spintronic devices June 14th, 2019

Cancer

A molecular glue to overcome cancer drug resistance? Small molecule drug may prevent chemotherapy resistance June 7th, 2019

Chemists build a better cancer-killing drill: Rice U.-designed molecular motors get an upgrade for activation with near-infrared light May 29th, 2019

New efficient way to engineer nanostructures mimicking natural immune response complexes: Novel method to engineer large multi-antibody-like nanostructures using DNA nanotechnology; the results demonstrate the potential for assembly of multiple proteins and also other materials t May 10th, 2019

A cautionary tale for researchers working on selective drug delivery May 9th, 2019

Govt.-Legislation/Regulation/Funding/Policy

'Hot spots' increase efficiency of solar desalination: Rice University engineers boost output of solar desalination system by 50% June 19th, 2019

New record: 3D-printed optical-electronic integration June 18th, 2019

Can break junction techniques still offer quantitative information at single-molecule level June 18th, 2019

Mysterious Majorana quasiparticle is now closer to being controlled for quantum computing: Princeton researchers detect a robust Majorana quasiparticle and show how it can be turned on and off June 14th, 2019

Nanomedicine

A molecular glue to overcome cancer drug resistance? Small molecule drug may prevent chemotherapy resistance June 7th, 2019

Arrowhead Pharmaceuticals to Present at Upcoming June 2019 Conferences June 2nd, 2019

Chemists build a better cancer-killing drill: Rice U.-designed molecular motors get an upgrade for activation with near-infrared light May 29th, 2019

Light and nanotechnology combined to prevent biofilms on medical implants May 24th, 2019

Discoveries

'Hot spots' increase efficiency of solar desalination: Rice University engineers boost output of solar desalination system by 50% June 19th, 2019

New record: 3D-printed optical-electronic integration June 18th, 2019

Can break junction techniques still offer quantitative information at single-molecule level June 18th, 2019

University of Konstanz researchers create uniform-shape polymer nanocrystals: Researchers from the University of Konstanz's CRC 1214 'Anisotropic Particles as Building Blocks: Tailoring Shape, Interactions and Structures' generate uniform-shape nanocrystals using direct polymeriz June 14th, 2019

Announcements

'Hot spots' increase efficiency of solar desalination: Rice University engineers boost output of solar desalination system by 50% June 19th, 2019

New record: 3D-printed optical-electronic integration June 18th, 2019

Can break junction techniques still offer quantitative information at single-molecule level June 18th, 2019

Small currents for big gains in spintronics: A new low-power magnetic switching component could aid spintronic devices June 14th, 2019

Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers

'Hot spots' increase efficiency of solar desalination: Rice University engineers boost output of solar desalination system by 50% June 19th, 2019

New record: 3D-printed optical-electronic integration June 18th, 2019

Can break junction techniques still offer quantitative information at single-molecule level June 18th, 2019

University of Konstanz researchers create uniform-shape polymer nanocrystals: Researchers from the University of Konstanz's CRC 1214 'Anisotropic Particles as Building Blocks: Tailoring Shape, Interactions and Structures' generate uniform-shape nanocrystals using direct polymeriz June 14th, 2019

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project